Mark S. Paxton serves as CEO of Rx-360, an international pharmaceutical supply chain consortium dedicated to patient safety by promoting practices to protect supply chains and distribution channels. Rx-360 is based in Washington, DC. Prior to joining Rx-360, Mark served as a Regulatory Counsel in the CDER Office of Compliance where he was responsible for developing supply chain security policies, both domestically and internationally, including serving as the overseer of a major global initiative under the auspices of Asia-Pacific Economic Cooperation (APEC) to establish best practices for ensuring product quality moving in international commerce. Before joining FDA, Mark served as Associate Vice-President, International Regulatory Affairs at the Pharmaceutical Research and Manufacturers of America (“PhRMA”). In that capacity, Mark established a number of on-going dialogs and work programs with drug regulatory authorities throughout, Japan, China, East Asia, India, Europe and Latin America. These efforts were designed to assist regulators and constituent companies operating in these markets to better understand complex regulatory issues arising from the globalization of the pharmaceutical industry.
Mark is a regulatory attorney by education, experience, and training, and prior to joining PhRMA was in private practice in Lexington, Kentucky where he focused his practice on food and drug law. Mark received his B.S. (1991) and M.S. (1993) degrees in Economics from the University of Kentucky, and his J.D. from the University of Dayton School of Law in 1998.